BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1643250)

  • 1. Oxidation of aflatoxins and sterigmatocystin by human liver microsomes: significance of aflatoxin Q1 as a detoxication product of aflatoxin B1.
    Raney KD; Shimada T; Kim DH; Groopman JD; Harris TM; Guengerich FP
    Chem Res Toxicol; 1992; 5(2):202-10. PubMed ID: 1643250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1, and sterigmatocystin and activities of the epoxides in forming guanyl-N7 adducts and inducing different genetic responses.
    Baertschi SW; Raney KD; Shimada T; Harris TM; Guengerich FP
    Chem Res Toxicol; 1989; 2(2):114-2. PubMed ID: 2519710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
    Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver.
    Shimada T; Guengerich FP
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):462-5. PubMed ID: 2492107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the aflatoxin cyclopentenone ring to a delta-lactone reduces intercalation with DNA and decreases formation of guanine N7 adducts by aflatoxin epoxides.
    Raney KD; Gopalakrishnan S; Byrd S; Stone MP; Harris TM
    Chem Res Toxicol; 1990; 3(3):254-61. PubMed ID: 2131838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro.
    Essigmann JM; Croy RG; Nadzan AM; Busby WF; Reinhold VN; Büchi G; Wogan GN
    Proc Natl Acad Sci U S A; 1977 May; 74(5):1870-4. PubMed ID: 266709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
    Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
    Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of aflatoxin B1 in the isolated nuclei of rat liver.
    Yoshizawa H; Uchimaru R; Ueno Y
    J Biochem; 1981 Feb; 89(2):443-52. PubMed ID: 6787032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of butylated hydroxytoluene on the in vitro metabolism, DNA-binding and mutagenicity of aflatoxin B1 in the rat.
    Fukayama MY; Hsieh DP
    Food Chem Toxicol; 1984 May; 22(5):355-60. PubMed ID: 6427081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative mutagenicity of palmotoxin Bo and aflatoxins B1 and M1.
    Uwaifo AO; Emerole GO; Bababunmi EA; Bassir O
    J Environ Pathol Toxicol; 1979; 2(4):1099-107. PubMed ID: 109559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of aflatoxin B1 oxidation by gestodene action on human liver microsomes.
    Kim BR; Oh HS; Kim DH
    Biochem Mol Biol Int; 1997 Nov; 43(4):839-46. PubMed ID: 9385444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reduced mutagenicity of aflatoxin B1 due to hydroxylation: observations on five Salmonella typhimurium tester strains.
    Uwaifo AO; Bababunmi EA
    Cancer Lett; 1979 Aug; 7(4):221-5. PubMed ID: 389414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of aflatoxin B1 metabolic profiles and reduction of aflatoxin B1 mutagenicity by hepatic microsomes of rats fed butylated hydroxyanisole.
    Choi CY; Park SH; Park EH; Cha YN
    J Toxicol Sci; 1991 Feb; 16 Suppl 1():119-32. PubMed ID: 1920539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation and inactivation of carcinogenic dihaloalkanes and other compounds by glutathione S-transferase 5-5 in Salmonella typhimurium tester strain NM5004.
    Shimada T; Yamazaki H; Oda Y; Hiratsuka A; Watabe T; Guengerich FP
    Chem Res Toxicol; 1996; 9(1):333-40. PubMed ID: 8924613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epoxidation of aflatoxin B1 by Aspergillus flavus microsomes in vitro: interaction with DNA and formation of aflatoxin B1-glutathione conjugate.
    Saxena M; Allameh A; Mukerji KG; Raj HG
    Chem Biol Interact; 1991; 78(1):13-22. PubMed ID: 1901247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromatographic and spectroscopic properties of hemiacetals of aflatoxin and sterigmatocystin metabolites.
    Orti DL; Grainger J; Ashley DL; Hill RH
    J Chromatogr; 1989 Jan; 462():269-79. PubMed ID: 2738124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The response of Xeroderma pigmentosum cells and controls to the activated mycotoxins, aflatoxins and sterigmatocystin.
    Stich HF; Laishes BA
    Int J Cancer; 1975 Aug; 16(2):266-74. PubMed ID: 1171827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation.
    Ramsdell HS; Eaton DL
    Cancer Res; 1990 Feb; 50(3):615-20. PubMed ID: 2105159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aflatoxin B1 mutagenesis, DNA binding, and adduct formation in Salmonella typhimurium.
    Stark AA; Essigmann JM; Demain AL; Skopek TR; Wogan GN
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1343-7. PubMed ID: 375236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.